Effects of hyperoxia on cytoplasmic thioredoxin system in alveolar type epithelial cells of premature rats

Abstract

This study investigated the effects of hyperoxia on dynamic changes of thioredoxin-1 (Trx1) and thioredoxin reductase-1 (TrxR1) in alveolar type II epithelial cells (AECII) of premature rats. Pregnant Sprague-Dawley rats were sacrificed on day 19 of gestation. AECII were isolated and purified from the lungs of premature rats. When cultured to 80% confluence, in vitro cells were randomly divided into air group and hyperoxia group. Cells in the hyperoxia group were continuously exposed to 95% O₂/5% CO₂ and those in the air group to 95% air/5% CO₂. After 12, 24 and 48 h, cells in the two groups were harvested to detect their reactive oxygen species (ROS), apoptosis, TrxR1 activity and the expressions of Trx1 and TrxR1 by corresponding protocols, respectively. The results showed that AEC II exposed to hyperoxia generated excessive ROS and the apoptosis percentage in the hyperoxia group was increased significantly at each time points as compared with that in the air group (P<0.001). Moreover, TrxR1 activity was found to be markedly depressed in the hyperoxia group in comparison to that in the air group (P<0.001). RT-PCR showed the expressions of both Trx1 and TrxR1 mRNA were significantly increased in AECII exposed to hyperoxia for 12 and 24 h (P<0.01), respectively. At 48 h, the level of Trx1 mRNA as well as that of TrxR1 mRNA in the hyperoxia group was reduced and showed no significant difference from that in the air group (P>0.05). Western blotting showed the changes of Trx1 protein expressions in the hyperoxia group paralleled those of Trx1 mRNA expressions revealed by RT-PCR. It was concluded that hyperoxia can up-regulate the protective Trx1/TrxR1 expressed by AECII in a certain period, however, also cause dysfunction of the cytoplasmic thioredoxin system by decreasing TrxR1 activity, which may contribute to the progression of oxidative stress and cell apoptosis and finally result in lung injury.

Keywords

hyperoxia / thioredoxin-1 / thioredoxin reductase-1 / lung injury / alveolar type II epithelial cell / apoptosis / premature rats

References

[1] Luna ParedesM.C., Asensio de la CruzO., et al.. Oxygen therapy in acute and chronic conditions: Indications, oxygen systems, assessment and follow-up. An Pediatr (Barc), 2009, 71(2): 161-174

[2] BhandariV.. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med, 2010, 15(4): 223-229

[3] GoreA., MuralidharM., EspeyM.G., et al.. Hyperoxia sensing: From molecular mechanisms to significance in disease. J Immunotoxicol, 2010, 7(4): 239-254

[4] BalasubramaniamV., MervisC.F., MaxeyA.M., et al.. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol, 2007, 292(5): 1073-1084

[5] FreemanB.A., MasonR.J., WilliamsM.C., et al.. Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia. Exp Lung Res, 1986, 10(2): 203-222

[6] CrapoJ.D., HayatdavoudiG., KnappM.J., et al.. Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 days. Am J Physiol, 1994, 267(6Pt1): L797-806

[7] BarazzoneC., WhiteC.W.. Mechanisms of cell injury and death in hyperoxia: Role of cytokines and Bcl-2 family proteins. Am J Respir Cell Mol Biol, 2000, 22(5): 517-519

[8] FreemanB.A., CrapoJ.D.. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem, 1981, 256(21): 10986-10992

[9] BarazzoneC., HorowitzS., DonatiY.R., et al.. Oxygen toxicity in mouse lung: Pathways to cell death. Am J Respir Cell Mol Biol, 1998, 19(4): 573-581

[10] MantellL.L., HorowitzS., DavisJ.M., et al.. Hyperoxia-induced cell death in the lung—the correlation of apoptosis, necrosis, and inflammation. Ann N Y Acad Sci, 1999, 887: 171-180

[11] LilligC.H., HolmgrenA.. Thioredoxin and related molecules—from biology to health and disease. Antioxid Redox Signal, 2007, 9(1): 25-47

[12] HolmgrenA., LuJ.. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun, 2010, 396(1): 120-124

[13] HolmgrenA., BjörnstedtM.. Thioredoxin and thioredoxin reductase. Methods Enzymol, 1995, 252: 199-208

[14] ArnérE.S.. Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions. Biochim Biophys Acta, 2009, 1790(6): 495-526

[15] HamadaY., FujiiH., KitazawaR., et al.. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: A novel role of oxidative stress and therapeutic implications. Bone, 2009, 44(5): 936-941

[16] ErikssonS.E., Prast-NielsenS., FlabergE., et al.. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic Biol Med, 2009, 47(11): 1661-1671

[17] PiedboeufB., FrenetteJ., PetrovP., et al.. In vivo expression of intercellular adhesion molecule 1 in type II pneumocytes during hyperoxia. Am J Respir Cell Mol Biol, 1996, 15: 71-77

[18] CrapoJ.D.. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol, 1986, 48: 721-731

[19] ZhuH., ChangL., LiW., et al.. Effect of amygdalin on the proliferation of hyperoxia-exposed type II alveolar epithelial cells isolated from premature rat. J Huazhong Univ Sci Technolog Med Sci, 2004, 24(3): 223-225

[20] GantherH., IpC.. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr, 2001, 131(2): 301-304

[21] MyersC.R., MyersJ.M.. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology, 2009, 257(1–2): 95-104

[22] Kaimul AhsanM., NakamuraH., TanitoM., et al.. Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced down-regulation of Akt. Free Radic Biol Med, 2005, 39(12): 1549-1559

[23] YamadaT., IwasakiY., NagataK., et al.. Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. Pulm Pharmacol Ther, 2007, 20(6): 650-659

[24] ImenJ.S., BillietL., Cuaz-PérolinC., et al.. The regulated in development and DNA damage response 2 (REDD2) gene mediates human monocyte cell death through a reduction in thioredoxin-1 expression. Free Radic Biol Med, 2009, 46(10): 1404-1410

[25] NakamuraH., TamuraS., WatanabeI., et al.. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett, 2002, 82(1–2): 165-170

[26] WatanabeR., NakamuraH., MasutaniH., et al.. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther, 2010, 127(3): 261-270

[27] SatoA., HoshinoY., HaraT., et al.. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. J Pharmacol Exp Ther, 2008, 325(2): 380-388

[28] HaendelerJ., TischlerV., HoffmannJ., et al.. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett, 2004, 577(3): 427-433

[29] ImJ.Y., LeeK.W., JunnE., et al.. DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci Res, 2010, 67(3): 203-208

[30] ArnerE., HolmgrenA.. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 2000, 267: 6102-6109

[31] KabuyamaY., KitamuraT., YamakiJ., et al.. Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells. Biochem Biophys Res Commun, 2008, 367(2): 491-496

[32] MitchellJ., MorrisA., de BellerocheJ.. Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset. Free Radic Biol Med, 2009, 46(2): 202-211

[33] GandinV., FernandesA.P., RigobelloM.P., et al.. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol, 2010, 79(2): 90-101

[34] HamaI., NakagomiS., KonishiH., et al.. Simultaneous expression of glutathione, thioredoxin-1, and their reductases in nerve transected hypoglossal motor neurons of rat. Brain Res, 2010, 1306: 1-7

[35] BrandtW., WessjohannL.A.. The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: Proposition of a swapping catalytic triad including a Sec-His-Glu state. Chem Bio Chem, 2005, 6: 386-394